ADHD

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

COPD… nasal polyps.. gout …. dyskinesia in Parkinson Disease: here’s a brief look at new drugs for these and other disorders coming your way.

A first-of-its-kind study applies traditional growth-charting to evaluate abnormal developmental patterns in connectivity networks of a child's brain.

Most significant were positive changes in motivation to complete mental work and in vigor, fatigue, and depression.

ADHD: seen only in kids; boys are more impaired vs girls; only stimulants work. Myths or facts?

What does ADHD look like in adults? What signs/symptoms should be on your radar? Find out what you know and what you need to know.

Attention to ADD seems to be escalating. It almost seems to be a fad. Doesn’t everyone want to be able to focus better?

Attention-deficit/hyperactivity disorder and oppositional defiant disorder are both considered disruptive behavior disorders, but the 2 disorders are distinct, having different etiologies and responding to different types of treatment.

Despite its caveats and good intentions, the AAP guideline will surely invite an inappropriate glut of medication for preschoolers . . .

About half of children with ADHD also meet the diagnostic criteria for ODD but the disorders have different etiologies and respond to different types of treatment.

In the past 15 years, there has been an increasing awareness of the syndromal persistence of attention-deficit/ hyperactivity disorder (ADHD) into adulthood.

A 9-year-old asymptomatic boy was referred to our tertiary care facility with a blood lead level (BLL) of 59 μg/dL. A diagnosis of attention deficit hyperactivity disorder, which was managed with amphetamine/dextroamphetamine, had been made when the patient was 6 years old.

CINCINNATI -- Almost 9% of U.S. children ages 8 to 15 meet standard diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD), but less than half of them receive treatment.

MONTREAL -- For children with attention-deficit hyperactivity disorder who sleep poorly, methylphenidate (Ritalin) helps make them alert when they are awake.

NEW YORK -- Most kids with attention deficit hyperactivity disorder (ADHD) get better over time with treatment, regardless of what that treatment is, according to observational follow-up of a major study.

SAN DIEGO -- When attention deficit hyperactivity disorder meets bipolar disorder in an adult, the diagnosis is hard and the course is poorly understood but the co-morbidity appears to exacerbate matters, researchers said here.

SAN FRANCISCO -- Given the high prevalence of substance abuse in patients with attention deficit hyperactivity disorder (ADHD), psychiatrists need to consider comorbidity in assessment of both conditions.

ROCKVILLE, Md. -- The FDA has approved lisdexamfetamine dimesylate (Vyvanse), formerly known as NRP104, for attention deficit hyperactivity disorder.

ROCKVILLE, Md. -- The FDA has ordered all drugs approved for attention deficit hyperactivity disorder to carry guides to inform patients about the potential for cardiovascular risks and adverse psychiatric symptoms.

NEW ORLEANS -- Although pharmacological treatments are the mainstay of therapy for attention-deficit hyperactivity disorder (ADHD) in adults, psychosocial treatments can be a useful adjunct and improve patients' quality of life.

NEW ORLEANS -- Attention-deficit hyperactivity disorder (ADHD), often thought of as a condition of childhood, may persist into adolescence and adulthood, causing serious life problems, investigators said here.

SAN DIEGO -- An investigational d-amphetamine prodrug appears to be effective in treating pediatric attention deficit hyperactivity disorder, with the goal of less abuse potential than amphetamines, researchers said.

SAN DIEGO, Calif. -- Strattera (atomoxetine) given to children with attention deficit hyperactivity disorder does not appear to stunt growth over the long term, according to a lengthy study.

ATLANTA ? Stimulants used to treat attention deficit-hyperactivity disorder (ADHD) that are accidentally overdosed or trigger adverse reactions lead to more than 3,000 emergency room visits a year, estimate CDC researchers.